Skip to contentSkip to footer
      employer cover photo

      Auriga Partners

      Is this your company?

      Find the right fit for you - faster

      Get tailored insights about working at Auriga Partners in one quick step.

      Auriga Partners Snapshot

      Be the first to review this company

      Bernard Daugeras

      Not enough data to show CEO approval

      Investment & Asset ManagementIndustry
      Description Auriga Partners keeps a sharp eye out for stellar investments in the life sciences and information technology industries. The venture capital firm, which was founded in 1998 by a trio of French VC veterans, focuses on early-stage European Union investments and takes a hands-on approach to developing its portfolio companies. Auriga Partners also considers investing in Israeli and North American firms. The firm typically spends an average E5 million ($7 million) per investment. Among Auriga Partners' former portfolio companies that have gone public are UK vaccine maker Acambis, French pharmaceutical company NicOx, and UK biotech firm Vernalis.

      Life at Auriga Partners

      Related searches: Auriga Partners jobs | Auriga Partners salaries | Auriga Partners benefits | Auriga Partners interviews
      CompaniesAbout Auriga Partners

      Glassdoor gives you an inside look at what it's like to work at Auriga Partners, including salaries, reviews, office photos, and more. This is the Auriga Partners company profile. All content is posted anonymously by employees working at Auriga Partners.